KCRS26 Leadership Committee

TONI CHOUEIRI, MD

COMMITTEE CO-CHAIR

Dana-Farber Cancer Institute

HANS HAMMERS, MD, PhD

COMMITTEE CO-CHAIR

UT Southwestern Medical Center

David Braun

ARI HAKIMI, MD, PhD

Memorial Sloan Kettering Cancer Center

RANA MCKAY, MD

University of California, San Diego

SUMANTA PAL, MD

City of Hope Comprehensive Cancer Center

Thomas Powles

THOMAS POWLES, MBBS, MRCP, MD

Barts Cancer Institute

BRYAN LEWIS

KidneyCAN CEO

SUSAN POTEAT

KidneyCAN Medical Science Liaison

Abstract Committee

David Braun

Adanma Ayanambakkam, MD

Oklahoma University Health

ABHISHEK CHAKRABORTY, PhD

Cleveland Clinic

THAI HO, MD, PhD

Medical University of South Carolina

RANA MCKAY, MD

University of California, San Diego

Charles Nguyen, MD

City of Hope Comprehensive Cancer Center

SUMANTA PAL, MD

City of Hope Comprehensive Cancer Center

Brad McGregor

JUDITH VARNER, PhD

University of California, San Diego

Brad McGregor

WESLEY YIP, MD

City of Hope Comprehensive Cancer Center

Communications Committee

David Braun

CRISTIANE BERGEROT, PhD

CETTRO Cancer Research Hospital in Brasilia

David Braun

NAZLI DIZMAN, MD

MD Anderson Cancer Center

PAVLOS MSAOUEL, MD, PhD

MD Anderson Cancer Center

RENEE MARIA SALIBY, MD

Yale School of Medicine

MICHAEL SERZAN, MD

Dana-Farber Cancer Institute

YUKSEL URUN, MD

Ankara University School of Medicine

adrian hayes

ADRIAN HAYES

KidneyCAN Communications

QING ZHANG, PhD

UT Southwestern Medical Center

kcrs26 day one

Keynote Speaker

Membrane Synthesis as a Potential Achilles’ Heel of Renal Carcinoma

Chung Han Lee

CRAIG B. THOMPSON, MD

Memorial Sloan Kettering Cancer Center

session 1

Current Role of Artificial Intelligence in Kidney Cancer

MODERATORS

David Braun

ARI HAKIMI, MD, PhD

Memorial Sloan Kettering Cancer Center

ELIEZER VAN ALLEN, MD

Dana-Farber Cancer Institute

speakers

SYLVAN BACA, MD, PhD

Dana-Farber Cancer Institute

HARI KASI

Almara, Inc.

JULIE STEIN DEUTSCH, MD

Johns Hopkins Medicine

ANDREW SMITH, MD, PhD

St. Jude Children’s Research Hospital

session 2

Sustaining Momentum in Kidney Cancer Research in an Era of Reduced Federal Funding

MODERATOR

MICHAEL ATKINS, MD

Georgetown Lombardi Comprehensive Cancer Center

SPEAKERS

JAMES BRUGAROLAS, MD, PhD

UT Southwestern Medical Center

David Braun

ABHISHEK CHAKRABORTY, PhD

Cleveland Clinic

ERIC JONASCH, MD

MD Anderson Cancer Center

David Braun

DAVID McDERMOTT, MD

Beth Israel Deaconess Medical Center

moderated panel discussion

JAMES BRUGAROLAS, MD, PhD

UT Southwestern Medical Center

David Braun

ABHISHEK CHAKRABORTY, PhD

Cleveland Clinic

TONI CHOUEIRI, MD

Dana-Farber Cancer Institute

ERIC JONASCH, MD

MD Anderson Cancer Center

David Braun

DAVID McDERMOTT, MD

Beth Israel Deaconess Medical Center

Fireside Chat with Arie Belldegrun, MD

In conversation with Michael Atkins, Georgetown-Lombardi Comprehensive Cancer Center, and Toni Choueiri, Dana-Farber Cancer Institute

Innovation, Investment, and the Future of Kidney Cancer Research

Chung Han Lee

ARIE BELLDEGRUN, MD

Founder & Senior Managing Director, Vida Ventures

Roy & Carol Doumani Chair in Urologic Oncology
Professor of Urology, Research
Director & Founder, Institute of Urologic Oncology, Emeritus
David Geffen School of Medicine, UCLA Health

Executive Chairman & Co-Founder, Allogene Therapeutics
Chairman, UroGen Pharma

session 3

Best of KCRS – Plenary Abstract Session

MODERATORS

David Braun

DAVID McDERMOTT, MD

Beth Israel Deaconess Medical Center

David Braun

LAURENCE ALBIGES, MD, PhD

Gustave Roussy

SPEAKERS

Brad McGregor

JAMES JONES, MD

University of Cambridge

RANA MCKAY, MD

University of California, San Diego

Thomas Powles

THOMAS POWLES, MBBS, MRCP, MD

Barts Cancer Institute

session 4

Oral Abstract Presentations

MODERATORS

RANA MCKAY, MD

University of California, San Diego

David Braun

Adanma Ayanambakkam, MD

Oklahoma University Health

speakers

Mehmet Bilan

ZIAD EL BAKOUNY, MD

Memorial Sloan Kettering Cancer Center

Mehmet Bilan

PRAFUL RAVI, MB, BChir, MRCP

Dana-Farber Cancer Institute

Thomas Powles

RISHABH ROUT

Yale School of Medicine

KARIE RUNCIE, MD

Columbia University Herbert Irving Comprehensive Cancer Center

NICHOLAS SALGIA, MD, PhD

Roswell Park Comprehensive Cancer Center

Brad McGregor

WENXIN (VINCENT) XU, MD

Dana-Farber Cancer Institute

kcrs26 day two

Founding Partner Presentation:

Exelixis-Driven Progress in Renal Cell Carcinoma: Evidence Today and the Pipeline Ahead

Mehmet Bilan

TASHA HALL, PhD

Exelixis

session 5

Next-Generation Immunotherapy:
Emerging Science and New Approaches

MODERATORS

HANS HAMMERS, MD, PhD

UT Southwestern Medical Center

David Braun

DAVID BRAUN, MD, PhD

Yale School of Medicine

SPEAKERS

Ken Batai

FIONA AN, MD

Summit Therapeutics

David Braun

JOHN CONNOLLY, PhD

Parker Institute for Cancer Immunotherapy

David Braun

WILLIAM FREED-PASTOR, MD, PhD

Dana-Farber Cancer Institute

Ken Batai

BERTRAND ROUTY, MD, PhD

University of Montreal

session 6

Shaping the Next Standard of Care for RCC Brain Metastases

MODERATORS

MICHAEL HURWITZ, MD, PhD

Yale Medicine

Brad McGregor

Ritesh Kotecha, MD

Memorial Sloan Kettering Cancer Center

SPEAKERS

David Braun

ROY ELIAS, MD

Johns Hopkins University

Brad McGregor

ELSHAD HASANOV, MD, PhD

The Ohio State University

David Braun

HARRIET KLUGER, MD

Yale School of Medicine

RAJ SINGH, MD

Baptist Health South Florida Lynn Cancer Institute

session 7

Trials in Progress Presentations

MODERATORS

David Braun

NAOMI HAAS, MD

Abramson Cancer Center

Charles Nguyen, MD

City of Hope Cancer Center

SPEAKERS

TONI CHOUEIRI, MD

Dana-Farber Cancer Institute

ABHIRAMI DAS, MD

The University of Oklahoma College of Medicine

SAHIL DOSHI, MD

Memorial Sloan Kettering Cancer Center

HENRY LITT, MD

University of Pennsylvania

RANA MCKAY, MD

University of California, San Diego

PAVLOS MSAOUEL, MD, PhD

MD Anderson Cancer Center

session 8

RCC Breakthroughs:
Highlights from AACR, ASCO, ESMO, ASCO GU

MODERATORS

TONI CHOUEIRI, MD

Dana-Farber Cancer Institute

Thomas Powles

THOMAS POWLES, MBBS, MRCP, MD

Barts Cancer Institute

SPEAKERS

David Braun

LAURENCE ALBIGES, MD, PhD

Gustave Roussy

KATY BECKERMANN, MD, PhD

Tennessee Oncology

MICHAEL SERZAN, MD

Dana-Farber Cancer Institute

TIAN ZHANG, MD

UT Southwestern Medical Center

session 9

Rapid Oral Abstract Presentations – Part One

MODERATORS

SUMANTA PAL, MD

City of Hope Comprehensive Cancer Center

David Braun

ABHISHEK CHAKRABORTY, PhD

Cleveland Clinic

SPEAKERS

PAULO SIQUEIRA DO AMARAL, MD

Northwestern University

David Braun

Adanma Ayanambakkam Attanathi, MD

Oklahoma University Health

David Braun

HEDYEH EBRAHIMI, MD, MPH

Beth Israel Deaconess Medical Center

SOKI KASHIMA, MD, PhD

Yale School of Medicine

MICHAEL SERZAN, MD

Dana-Farber Cancer Institute

session 10

Rapid Oral Abstract Presentations – Part Two

MODERATORS

JUDITH VARNER, PhD

University of California, San Diego

David Braun

Wesley Yip, MD

City of Hope Comprehensive Cancer Center

SPEAKERS

HANS HAMMERS, MD, PhD

UT Southwestern Medical Center

GIULIANA MOGNOL, PhD

University of California, San Diego

YUFEI WANG, PhD

Dana-Farber Cancer Institute

David Braun

RAHUL WINAYAK, MBChB

City of Hope Comprehensive Cancer Center

YU-WEI CHEN, MD, MS

University of California, San Diego